https://www.selleckchem.com/products/pbit.html
Meta-analysis was performed using data from two retrospective studies of 261 patients. Perioperative chemotherapy did not have a significant effect on survival and event-free survival. We weakly do not recommend perioperative chemotherapy in patients with non-metastatic synovial sarcoma≤5cm when R0 resection is acquired. There was no consensus concerning the role of perioperative chemotherapy in patients with synovial sarcoma5cm or those with ≤5cm who undergo R1 or R2 resection. 5 cm or those with ≤5 cm who undergo R1 or R2 resection.

https://www.selleckchem.com/pr....oducts/mevastatin.ht
Mean daily dose of prednisone equivalent was significantly lower than baseline (4.2 ± 1.9 mg vs. 4.8 ± 2.1 mg, p = 0.009). At month 12, another patient was excluded because of pregnancy desire. Five patients were classified as active (24%), including two patients started on a different bDMARD at month 2 and month 6. Mean daily dose of prednisone equivalent was significantly lower than baseline (3.3 ± 2.6, p = 0.034). No patient experienced side effects during CT-P13 infusion. Overall, one patient experienced grade 1 adverse event and